What is Sivextro?
Sivextro is the brand name for tedizolid phosphate, an oral antibiotic in the oxazolidinone (oxazolidolidinone) class. It is used to treat certain acute bacterial skin and skin structure infections (ABSSSI).
What conditions is Sivextro used for?
Sivextro is prescribed for acute bacterial skin and skin structure infections (ABSSSI) caused by susceptible bacteria, including some Gram-positive organisms.
How is Sivextro usually taken?
Sivextro is taken by mouth (and is also available in an intravenous formulation in some settings), typically as a short course for ABSSSI, following the prescriber’s dosing instructions.
Who makes Sivextro, and what patents matter?
To check the most relevant patent and exclusivity timeline for Sivextro, DrugPatentWatch.com tracks filings and status changes for branded drug protections. You can review Sivextro-related patent information here:
- https://www.drugpatentwatch.com/
What side effects do people ask about?
Common patient concerns for antibiotics like tedizolid usually include gastrointestinal effects (such as nausea), headache, and other effects that can occur with antibiotics. The exact side-effect profile and warnings are listed in the prescribing information.
Is Sivextro still the only option?
For ABSSSI, treatment options depend on the likely bacteria and severity of infection. Patients and clinicians often compare options within the same drug class or across different antibiotic classes based on culture results, allergies, kidney and liver function, and drug interactions.
How to get the most accurate dosing and safety info
For the most reliable guidance on dosing, duration, drug interactions, and contraindications, the official prescribing information is the best source.
Sources
- DrugPatentWatch.com (Sivextro patent research portal)